<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7303642\results\search\zoonosis\results.xml">
  <result pre="low, direct data evaluating the safety of such agents in" exact="coronavirus disease 2019" post="(COVID-19) are scarce. This article reviews and offers guidance"/>
  <result pre="therapy medical dermatology SARS-CoV-2 Abbreviations used CI, confidence interval COVID-19," exact="coronavirus disease 2019" post="IL, interleukin MERS, Middle East respiratory syndrome OR, odds"/>
  <result pre="CI, confidence interval COVID-19, coronavirus disease 2019 IL, interleukin MERS," exact="Middle East respiratory syndrome" post="OR, odds ratio RR, relative risk SARS, severe acute"/>
  <result pre="Capsule Summary â€¢This article adds to the limited literature on" exact="coronavirus disease 2019" post="(COVID-19) and immunosuppression. It provides expert opinion based on"/>
  <result pre="shared decision-making process concerning immunosuppressive and immunomodulatory therapy during the" exact="coronavirus disease 2019" post="pandemic 1.The severity of the underlying disease, with special"/>
  <result pre="disease course similar to previous highly pathogenic coronavirus infections (ie," exact="Middle East respiratory syndrome" post="[MERS] and severe acute respiratory syndrome [SARS]), with up"/>
  <result pre="data are needed to understand the impact of methotrexate on" exact="SARS-CoV-2 infection." post="Antimalarial drugs When used for their immunomodulatory properties, antimalarials"/>
  <result pre="small case series suggesting potential efficacy in the treatment of" exact="SARS-CoV-2 infection." post="Although inÂ vitro data suggest chloroquine and hydroxychloroquine both"/>
  <result pre="to fully characterize the risk of harm or benefit in" exact="SARS-CoV-2 infection." post="Anticytokine biologic therapy Data from BIOBADADERM (Spanish Registry ofÂ"/>
  <result pre="in psoriasis and found no significant increase in URI or" exact="influenza infection" post="rates compared with placebo.57 In contrast, Wan etÂ al58"/>
  <result pre="(5) 16 (3) AS, Ankylosing spondylitis; CD, Crohn's disease; COVID-19," exact="coronavirus disease 2019;" post="csDMARD, conventional synthetic disease-modifying antirheumatic drug; IBD, inflammatory bowel"/>
  <result pre="Table III Guidance statements for management of immunosuppression during the" exact="coronavirus disease 2019" post="(COVID-19) pandemicâˆ— Patients well-controlled on maintenance therapy We suggest"/>
  <result pre="FigÂ 1 Drug safety recommendations in the context of the" exact="coronavirus disease 2019" post="(COVID-19) pandemic. CMV, Cytomegalovirus; DVT, deep venous thrombosis; HZV,"/>
  <result pre="16HuiD.S.Systemic corticosteroid therapy may delay viral clearance in patients with" exact="Middle East respiratory syndrome" post="coronavirus infectionAm J Respir Crit Care Med19762017700701 17ArabiY.M.MandourahY.Al-HameedF.Corticosteroid therapy"/>
  <result pre="29MagagnoliJ.NarendranS.PereiraF.Outcomes of hydroxychloroquine usage in United States veterans hospitalized with" exact="Covid-19" post="[preprint]medRxiv202010.1101/2020.04.16.20065920 30TangW.CaoZ.HanM.Hydroxychloroquine in patients mainly with mild to moderate"/>
  <result pre="registry [e-pub ahead of print]Gastroenterology202010.1053/j.gastro.2020.05.032 74DamianiG.PacificoA.BragazziN.L.MalagoliP.Biologics increase the risk of" exact="SARS-CoV-2 infection" post="and hospitalization, but not ICU admission and death: real-life"/>
 </snippets>
</snippetsTree>
